A mouse mutant deficient in both neuronal ceroid lipofuscinosis-associated proteins CLN3 and TPP1

David E. Sleat, Whitney Banach-Petrosky, Katherine E. Larrimore, Yuliya Nemtsova, Jennifer A. Wiseman, Allison Najafi, Dymonn Johnson, Timothy A. Poole, Keigo Takahashi, Jonathan D. Cooper, Peter Lobel

Research output: Contribution to journalArticlepeer-review


Late-infantile neuronal ceroid lipofuscinosis (LINCL) and juvenile neuronal ceroid lipofuscinosis (JNCL) are inherited neurodegenerative diseases caused by mutations in the genes encoding lysosomal proteins tripeptidyl peptidase 1 (TPP1) and CLN3 protein, respectively. TPP1 is well-understood and, aided by animal models that accurately recapitulate the human disease, enzyme replacement therapy has been approved and other promising therapies are emerging. In contrast, there are no effective treatments for JNCL, partly because the function of the CLN3 protein remains unknown but also because animal models have attenuated disease and lack robust survival phenotypes. Mouse models for LINCL and JNCL, with mutations in Tpp1 and Cln3, respectively, have been thoroughly characterized but the phenotype of a double Cln3/Tpp1 mutant remains unknown. We created this double mutant and find that its phenotype is essentially indistinguishable from the single Tpp1−/− mutant in terms of survival and brain pathology. Analysis of brain proteomic changes in the single Tpp1−/− and double Cln3−/−;Tpp1−/− mutants indicates largely overlapping sets of altered proteins and reinforces earlier studies that highlight GPNMB, LYZ2, and SERPINA3 as promising biomarker candidates in LINCL while several lysosomal proteins including SMPD1 and NPC1 appear to be altered in the Cln3−/− animals. An unexpected finding was that Tpp1 heterozygosity significantly decreased lifespan of the Cln3−/− mouse. The truncated survival of this mouse model makes it potentially useful in developing therapies for JNCL using survival as an endpoint. In addition, this model may also provide insights into CLN3 protein function and its potential functional interactions with TPP1.

Original languageEnglish
Pages (from-to)720-734
Number of pages15
JournalJournal of Inherited Metabolic Disease
Issue number4
StatePublished - Jul 2023


  • CLN3 protein
  • mouse
  • neuronal ceroid lipofuscinosis
  • tripeptidyl peptidase 1


Dive into the research topics of 'A mouse mutant deficient in both neuronal ceroid lipofuscinosis-associated proteins CLN3 and TPP1'. Together they form a unique fingerprint.

Cite this